WASHINGTON — Efforts to impose stricter controls on prescription drugs that are subject to rampant abuse have apparently failed after a groundswell of lobbying by pharmacists and drugstores, members of Congress said on Monday.

The proposed controls, sought by senators and law enforcement officials, would apply to products like hydrocodone that are used for the treatment of moderate to severe pain.

The Senate approved the new restrictions last month as part of a bill reauthorizing user fees for the Food and Drug Administration. The House version of the legislation does not address the issue. House and Senate negotiators announced Monday night that they had reached a bipartisan agreement on the overall bill, and said they hoped Congress would approve it by the end of the month.

Abuse of prescription medications has risen sharply in the last decade, with hydrocodone products among those most often misused, according to the Drug Enforcement Administration.